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Ezan Chaudhry:  
The Impact of Bariatric Surgery on Influenza Vaccination and Host Metabolism 
(Under the direction of Melinda A. Beck) 
 
 Bariatric surgery is the most effective method for weight loss in obese individuals. This is 
significant because obesity is associated with several co-morbidities, many of which have 
metabolic dysfunction as an underlying cause. One major obesity-associated co-morbidity is a 
compromised response to the influenza vaccine. Several questions remain unanswered with 
regard to bariatric surgery’s impact on obesity associated co-morbidities. In our study, we 
analyzed the impact of bariatric surgery on vaccine induced serum antibody levels and 
circulating nutrient and metabolic hormone/peptide levels. Our findings suggest altered serum 
antibody levels are not the mechanism through which obesity compromises the response to 
influenza vaccination. Additionally, our findings highlight the remedial effect of bariatric 
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CHAPTER 1: AIMS AND HYPOTHESIS 
 
Obesity is characterized by a state of low grade chronic inflammation and has been 
shown to result in disturbed levels of circulating nutrients as well as metabolic hormones14. 
Obesity has also been recognized as an independent risk factor for increased mortality due to 
influenza virus infection6. Neidich et al. demonstrated that obese individuals have increased 
susceptibility to the influenza virus despite vaccination16. Our study will evaluate the impact of 
bariatric surgery on the immune response to influenza vaccine by measuring vaccine induced 
serum antibody levels before and after surgery. We will further quantify circulating metabolic 
hormones and nutrients to determine if bariatric surgery can re-establish a state of metabolic 
normalcy. We hypothesize that if obese individuals undergo bariatric surgery, their immune 
response to influenza vaccine will become more similar to the response seen in healthy 
individuals and the body will be returned to a state of metabolic normalcy. 
Aim 1: Determine the effect of bariatric surgery on serum antibody levels against influenza. 
Obesity results in a compromised response to the influenza vaccine. We hypothesize that 
bariatric surgery should restore serum antibody levels to levels seen in healthy individuals. 
Aim 2: Determine the effect of bariatric surgery on circulating nutrients and metabolic 
hormones/peptides. 
Obesity has been shown to result in disturbed levels of circulating nutrients and metabolic 
hormones/peptides. We hypothesize that bariatric surgery should return nutrient and 




Aim 3: Identify if any significant correlations between antibody levels and nutrient/metabolic 
hormone levels exist.  
Little is known of how obesity compromises the immune response to the influenza vaccine. 
Determining if any correlations exist between antibody levels against influenza and aspects of 
host metabolism may provide some insight. We hypothesize that serum antibody levels will be 





































CHAPTER 2: INTRODUCTION 
 
2.1 The Influenza Virus   
 Every year, between 5,000 and 56,000 Americans die as a result of the influenza 
infection6. Globally, the influenza virus causes between 250,000 and 500,000 deaths per year 6. 
Influenza is a highly contagious respiratory tract infection that presents symptoms such as 
headaches, malaise, sore throat, congestion, body aches, and nausea or vomiting 6. 
 The influenza virus consists of segmented RNA encapsulated by a lipid envelope covered 
primarily by two viral peptides: hemagglutinin (HA) and neuraminidase (NA)6. HA and NA both 
recognize sialic acid, a diverse array of sugar units found on the carbohydrate side chains of cell-
surface glycoproteins and glycolipids4,27. The initiation of influenza infection begins when HA 
recognizes and binds to sialic acids4. Once virus has replicated within a host cell, NA removes 
sialic acid from cellular glycoproteins and glycolipids, as well as from viral HA and NA4. The 
cleavage of sialic residues on the cell surface can facilitate the release of new virus11. 
Furthermore, the actions of NA prevent the virus from re-infecting the same cells and from 
aggregating with each other via HA-sialic acid interactions4. HA and NA proteins are typically 
the target of antibodies that block infection4. 
There are 4 strains of influenza: A, B, C, and D; A and B are the most common infection 
causing strains in humans6. To date, only influenza A viruses have been known to cause flu 
pandemics1.  Influenza A viruses have various subtypes based on their hemagglutinin (HA) and 
neuraminidase (NA)1. There are 18 HA subtypes and 11 NA subtypes, meaning that a total of 
198 different influenza subtypes are possible1. However, only 131 have been detected in nature1. 
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Current subtypes that routinely circulate are A(H1N1) and A(H3N2); the currently circulating 
influenza A(H1N1) viruses are related to the 2009 flu pandemic1. 
Antigenic drift (mutations in virus genes that code for virus-surface proteins) in HA or 
NA which result from evolutionary pressures from host immunity allow for the virus to escape 
antibody detection generated against earlier influenzas strains. This can potentially cause 
influenza re-infection in the same individual6. 
2.2 The Adaptive Immune Response to Influenza 
 
The adaptive immune response to influenza consists of humoral and cellular mediated 
immunity and is mediated by virus specific antibodies and T-cells. 
2.21 Humoral Immunity 
In response to influenza infection the body produces virus specific antibodies. The 
production of antibodies for HA and NA are particularly important because the presence of these 
antibodies correlates with protective immunity11.  
Immunoglobulin A (IgA) and immunoglobulin G (IgG) antibodies play a prominent role 
in protection against influenza15.  Mucosal IgA antibodies are produced locally in mucosal 
tissues  and provide a first line of defense at the site of infection15. The presence of serum IgA is 
indicative of a recent influenza virus infection11. IgG antibodies are important for systemic 
immunity and provide long lasting protection against a specific influenza strain11. HA and NA 
specific antibodies are of the IgG class antibodies15. 
HA specific antibodies bind to the trimeric globular head of HA and inhibit the 
attachment and entry of influenza into the host cell11. These antibodies can also assist the 
phagocytosis of viral particles by Fc receptor expressing cells11. Additionally, antibodies binding 
to HA expressed on infected cells can mediate antibody-dependent cell-mediated cytotoxicity, 
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which is a process in which the IgG antibody is recognized and acted upon by an effector 
cell11,25. HA antibodies therefore can neutralize the influenza virus and are a good correlate of 
protective immunity.  
Antibodies specific to NA have protective potential11. NA specific antibodies inhibit the 
enzymatic activity of NA which facilitates the spread of virus via sialic acid cleavage. NA 
specific antibodies can also play a role in antibody-dependent cell mediated cytotoxicity to help 
clear virus infected cells.  
2.22 Cellular Immunity 
 CD4+ and CD8+ T-cells are induced upon infection with influenza11.  CD4+ cells become 
active after recognizing MHC class II virus associated peptides on antigen presenting cells11. 
Although CD4+ cells display cytolytic activity to a certain degree, their most important 
phenotype is that of T helper (Th) cells11. There are different subsets of Th cells based on their 
cytokine expression profiles. Th cells help coordinate the response of other immune cells through 
cell-cell interactions or by secreting cytokines after recognizing viral peptides bound to MHC 
class II molecules23.  
 CD8+ T cells primarily function in the form of cytotoxic T lymphocytes (CTLs) in 
response to viruses11. Upon influenza infection, these cells become activated in the lymphoid 
tissues and are recruited to the site of viral infection11. CTLs recognize virus infected cells and 
eliminate them via factors such as perforin and granzymes; perforins increase the permeability of 
the membranes of infected cells and granzymes induce apoptosis11. CTLs also release cytokines 
which improve antigen-presentation by inducing MHC expression, which further aids in 




2.3 The Influenza Vaccine 
 Vaccination is the primary method used to prevent the onset of influenza13. Due to 
antigenic drifts, the influenza vaccine has to be reformulated on a yearly bases. Yearly vaccines 
are formulated by evaluating influenza strains which circulated in previous years16. The vaccine 
typically contains two influenza A strains and either one or two influenza B strains. The vaccine 
contains either inactivated virus or isolated viral HA and NA with HA being the primary 
immunogen in influenza vaccines13. Therefore vaccines are standardized to the quantity of HA13.  
Antibodies induced via influenza vaccination can be measured with a hemagglutinin 
inhibition assay (HAI). An HAI assay quantifies the protective antibodies blocking the ability of 
the virus to agglutinate red blood cells (RBCs). An HAI titer of 40 or greater represents the range 
at which 50% of individuals should be protected from infection16. Protection against influenza 
infection increases up to a titer of 160; beyond this titer, further protection capacity is minimal16. 
2.4 Obesity and Increased Susceptibility to Influenza 
  
 Obesity is classified as a state of low-grade chronic inflammation and includes altered 
levels of circulating nutrients, metabolic hormones, and excess adiposity14. Although a multitude 
of causes lead to obesity, it is primarily caused by prolonged positive energy balance14. There are 
several co-morbidities associated with obesity, one of which is immune dysfunction14.  
 Various studies have shown altered immune cell function in obese individuals compared 
to healthy weight individuals. For example, it has been shown that circulating mononuclear cells 
in obese individuals display a pro-inflammatory state compared to healthy weight individuals5. 
Additionally, individuals with a mutation in the gene for leptin synthesis become morbidly obese 
and display a weakened immune response3. These, among other findings, suggest that obesity 
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can lead to an impaired immune system. One such consequence of the relationship between 
obesity and immune function is an increased risk of infection14. 
During the 2009 H1N1 influenza pandemic, obesity was recognized as an independent 
risk factor for increased morbidity and mortality due to the H1N1 infection6. Across the world 
data has shown that obese individuals were disproportionately represented among influenza 
related hospitalizations and deaths during the pandemic14. Kwong et. al demonstrated that during 
flu seasons in addition to the 2009 pandemic, obese individuals were at greater risk for 
respiratory hospitalizations12.  
In addition to increased susceptibility to infection, evidence suggests that obese 
individuals do not respond to vaccinations as effectively as healthy weight individuals14. Neidich 
et al. showed that vaccinated obese adults were twice as likely to develop influenza and influenza 
like symptoms compared to healthy weight adults16.  
Obesity has drastically risen over the past few decades. In the U.S. alone 37% of adults 
are obese16. Obese adults currently outnumber underweight adults, suggesting that the prevalence 
of obesity is a worldwide trend6. Given that obesity has been identified as an independent risk 
factor for influenza, this puts approximately 500 million obese individuals at risk for increased 
morbidity and mortality due to influenza worldwide6. 
2.5 Bariatric Surgery 
The long term results yielded by traditional weight loss methods such as dieting, exercise, 
or medications are typically poor9. Bariatric surgery is recognized as the most effective treatment 
for weight loss9. Currently established procedures in the U.S. include sleeve gastrectomy and 
laparoscopic Roux-en-Y gastric bypass among others. These surgeries are typically very safe and 
have a mortality rate of 0.3%9. 
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A sleeve gastrectomy, also known as a vertical sleeve gastrectomy or gastric sleeve 
procedure, involves the removal of the outer portion of the stomach leaving a small sleeve of 
stomach and the pylorus intact8. By reducing the size of the stomach, this purely restrictive 
procedure allows individuals to feel fuller after consuming fewer calories8. In a laproscopic 
Roux-en Y gastric bypass a large portion of the stomach is stapled off and the remaining upper 
portion is connected to a segment of the small intestine referred to as the Roux limb 21. This not 
only reduces the amount of food an individual can consume but also reduces the absorption of 


























CHAPTER 3: METHODS 
 
3.1 Study Design 
Participants were recruited as part of a prospective observational study carried out at 
UNC Hospital's GI Surgery & Burn Specialty Clinic, located at 101 Manning Drive, Chapel Hill, 
NC 27599. All subjects gave written, informed consent as part of the UNC TraCS study on 
Visceral Inflammation and Immunometabolism in response to Bariatric Surgery (VIIBS), and the 
protocol was reviewed and approved by the University of North Carolina at Chapel Hill 
Institutional Review Board.  
3.2 Participants  
A total of 37 participants were enrolled in the study between March 2019 and January 
2020. Recruitment criteria for the study were adults between the ages of 18 and 70 who consented 
to laparoscopic bariatric surgery. Exclusion criteria were individuals with immunocompromised 
systems, individuals taking immunosuppressing drugs, type 1 diabetics, and pregnant or 
breastfeeding women. At enrollment, informed consent, demographic characteristics and BMI 
were obtained. Blood samples from laparoscopic surgery candidates ages 30-65 years were 
obtained before and after surgery. Out of the 37 participants recruited, a sub-group of 14 
participants was chosen for analysis. A total of 15 serum samples from individuals (ages 38-65 
years) enrolled in a prior flu vaccine study were used as lean controls16. Lean controls were 
matched based on age and race. 
3.3 Serum Isolation  
 Bariatric surgery patient blood samples were taken in vacutainer tubes and diluted in a 1:1 
ratio with phosphate buffer saline (PBS)10. Samples were then layered on top of Lymphoprep in a 
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50 mL conical tube. Red blood cells, peripheral blood mononuclear cells, and serum were 
separated via density gradient centrifugation (1200g, 10 min)7. Serum was then collected with a 
Pasteur pipette and stored in a 2 mL cryogenic vial at -80°C. Lean control serum samples were 
obtained from a prior flu study16. 
3.4 Hemagglutination Inhibition (HAI) Assay 
Using a Hemagglutination inhibition assay (HAI), antibodies against the influenza 
A(H1N1) 2009 virus in patient serum samples were quantified. The influenza A(H1N1) strain was 
used because it has been prevalent in many influenza vaccines over the past few years so it was 
likely that all participants would have been vaccinated against this strain. HAI titers were 
determined for all sera samples obtained from participants pre and post-bariatric surgery as well 
as for lean controls. HAI titers were determined in accordance with World Health Organization 
guidelines29.  
3.5 Luminex bi-plex cytokine kit  
Bio-Plex multiplex immunoassays were used to quantify the presence of metabolic 
hormones and proteins in the sera of bariatric surgery patients before and after surgery and the sera 
of lean control patients. The Bio-Rad bio-plex pro human diabetes and adiponectin assay was 
utilized in accordance with the Bio-Rad protocol for the assay20. C-peptide, ghrelin, GIP, GLP-1, 
glucagon, insulin, leptin, PAI, resistin, visfatin, and adiponectin were quantified with the bio-plex 
immunoassay. 
3.6 EPIC Database 
 Information regarding the study participants circulating nutrient levels at the time of their 
first and second blood draws were obtained from UNC healthcare’s EPIC database. Glucose, iron, 
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ferritin, vitamins A, D, B1, B6, B12, A1c, AST, ALT, alkaline phosphatase, BUN, and creatine 
levels were obtained from EPIC. 
3.7 Statistics  
 Sera samples were placed into sub-groups categorized as pre-bariatric surgery, post 
bariatric surgery, and lean control. Pre-bariatric surgery and post bariatric surgery samples were 
considered matched pairs. A Shapiro-Wilks normality test was used to assess the distribution of 
data for each variable being measured. 
Variables were tested for significance between the three sub-groups. A Wilcoxon rank sum 
test or Mann Whitney test were used if the study population did not display normality for a 
variable. A Wilcoxon rank sum test was used for comparisons between matched pairs. A Mann-
Whitney test was used for comparisons between unpaired values. A one-way ANOVA test was 
used for comparisons between variables that met the criteria for a Gaussian distribution; Tukey’s 
multiple comparison test was used to further determine which sub-groups were statistically 
different. A p-value of a less than 0.05 was considered significant. 
A Kendall Tau correlation test was used to correlate HAI titers to nutrient and metabolic 
hormone/peptide levels in serum. The Kendall Tau test was used over a Spearman test because of 
the repetitive nature of HAI titer measurements and because of the small sample size. A p-value 
of a less than 0.05 was considered significant. 
All normality tests, tests of statistical difference and figures were run/created using the 






CHAPTER 4: RESULTS 
 
4.1 Demographics  
During the study year we enrolled 37 participants who underwent bariatric surgery at UNC 
Hospitals. Out of the 37 participants, 14 were selected for analysis of bariatric surgery’s impact on 
the response to the influenza vaccine and the metabolic profile. Of the 14 participants that received 
the intervention, 29% were male and 71% were female. Approximately 79% of the participants 
were Caucasian and 21% were African American. The average age of participants who received 
the intervention was 44 years with a standard deviation of 11 years. 
Table 1: Demographics of the Study Population 
 Measure Bariatric Surgery Participants Lean Control Participants 
Overall 
Total Number 14 15 
Age 44±11 49±9 
Sex 
Male 4 4 
Female 10 11 
Age 
Caucasian 11 12 
African American 3 3 











4.2 Serum Antibody Titers Pre and Post-Bariatric Surgery 
 To investigate the impact of bariatric surgery on the immune response to influenza 
vaccination, we measured patient serum antibody titers against HA before and after bariatric 
surgery using HAI assays. Serum antibody titers were also measured for lean control participants. 
Two bariatric surgery patients had HAI titers which were determined to be outliers and were 
excluded from analysis. The population did not display a Gaussian distribution for HAI titers when 
tested with the Shapiro-Wilks normality test (p=0.0001) (Figure 1). Pre and post-bariatric surgery 
antibody levels were not significantly different from each other based on the Wilcoxon rank-sum 
test (Figure 2). When the population was stratified based on gender and race, pre and post-bariatric 
surgery antibody levels were still not significantly different from one another. On average, 
antibody titers decreased after surgery from an average titer of 80.00 to an average of 60.00. 
Antibody levels against HA in post-surgery patients became more similar to lean control 
individuals as evidenced by both mean and median (Table 2). HAI titers were not significantly 









Figure 1: Distribution of HAI Titers in the Study Population 
A: The distribution of the study participants HAI titers was not normal. B: Quantiles for the 
population HAI titers were not comprable to quantiles for a normal distribution.  
 
Table 2. Descriptive Statistics of for HAI Titers Pre and Post-Surgery and for Lean Controls 
Condition Mean  Std. Dev. Std. Error Median 
Pre-Surgery Titers 75.00 59.16 17.08 80.00 
Post-Surgery Titers 65.00 53.34 15.40 60.00 
Lean Control Titers 66.00 55.39 14.30 40.00 
 



























Testing for Normality in




















Figure 2: Comparisons between HAI Titers in the study sub-groups 
Influenza A(H1N1) HAI titers for the pre-bariatric surgery, post bariatric surgery, and lean 
control participants. Pre and post-urgery titers were not statistically different. Pre and post-




















































4.3 The Impact of Bariatric Surgery on Host Metabolism  
 In order to measure the impact of bariatric surgery on aspects of host metabolism, 25 
nutrients and metabolic hormones/proteins were investigated (glucose, iron, ferritin, vitamins A, 
D, B1, B6, B12, A1c, AST, ALT, alkaline phosphatase, BUN, creatine, C-peptide, ghrelin, GIP, 
GLP-1, glucagon, insulin, leptin, PAI, resistin, visfatin, and adiponectin). Of these, sufficient 
data in regard to particpants iron, ferritin, vitamins, A, B1, and B6 were not available, and so 
these variabels were excluded from analysis. These variables were checked for statistical 
difference before and after surgery and for significance against lean controls. Variables that were 
statistically different before and after surgery are depicted in Table 3. The descriptive statistics 
for these variables are shown in Table 4. Figure 4 shows the mean with standard error or median 
level of visfatin, A1c, insulin, and resistin for each sub-group and depicts statistical significance 
between each group. These 4 variables saw a return to normalcy after surgery. The mean was 












Table 3: Distribution and Comparison to Lean Controls of Variables Statistically Different 
Pre vs. Post-Surgery 
Variables Statistically 
















































































• UNC Healthcare’s EPIC database lacked suficient data regarding the lean control participants 










Table 4: Descriptive Statistics of Variables Statistically Different before and after Surgery 
Variable Sub-Group Mean Median 
Vitamin D (25 OH) 
(ng/mL) 
Pre 22.87 22.20 
Post 33.73 33.60 
Lean NA NA 
Vitamin B12 (pg/mL) 
Pre 456.0 452.0 
Post 703.1 732.0 
Lean NA NA 
A1c 
Pre 5.964* 5.6* 
Post 5.28 5.3 
Lean 5.133 5.25 
C-peptide (pg/mL) 
Pre 2296* 2376* 
Post 1572* 1556* 
Lean 1005 1014 
Ghrelin (pg/mL) 
Pre 1391* 1366* 
Post 1256* 1162* 
Lean 2507 2542 
Glucagon (pg/mL) 
Pre 3495* 3484* 
Post 3189* 3220* 
Lean 2923 2925 
Inuslin (pg/mL) 
Pre 980.6* 801.2* 
Post 391.8 325.7 
Lean 259.8 221.8 
Leptin (pg/mL) 
Pre 42756* 46249* 
Post 20303* 19361* 
Lean 3449 2756 
Resistin (pg/mL) 
Pre 12758* 10717* 
Post 9703 8812 
Lean 7726 7215 
Visfatin (pg/mL) 
Pre 16057* 16220* 
Post 14013 13907 
Lean 13089 13455 
Adiponectin (pg/mL) 
Pre 8080283 8567250 
Post 9887750 9636200 
Lean 13512864 10746000 
• Variables are alternately bolded to aid in visually distinguishing between them. 





Figure 3: Comparisons between the 3 subgroups for Variables which saw a return to 
Normalcy 
The 4 metabolic variables depicted by this figure each saw a return to normalcy after bariatric 
surgery. Data for each variable was statistically different pre vs. post-surgery. The pre-surgery data 
was shown to be statistically different from the control group. However, the post-surgery data for 
each variable was not statistically different from the control group. For visfatin, the mean with 
standard error is shown since the data for visfatin was normally distributed. The other three 











4.4 HAI Titers as they relate to Cicrulating Nutrient and Hormone/Peptide levels. 
 HAI Titers were not significantly correlated with any of the nutrients or metabolic 
hormones/proteins measured. Based on the Kendall Tau test, correlations between HAI Titers 









































CHAPTER 5: DISCUSSION 
 
 Obesity is a disease that affects 13% of the world’s population and 37% of the U.S. 
population16. This disease, in addition to resulting in metabolic disturbances, has been identified 
as an independent risk factor for severity of influenza infection6. Furthermore, several studies 
have suggested that the response to influenza vaccination is impaired in obese individuals. This 
indicates that obesity not only plays a role in increasing the severity of this infection, but also 
plays a role in increasing susceptibility to the influenza virus.  
 Traditional weight loss methods such as dieting and exercise have been shown to return 
the body to a state of normalcy9. However, these methods have yielded poor weight loss results 
for obese individuals attempting to lose weight9.  Bariatric surgery on the other hand has much 
higher rates of success when considering weight loss in obese individuals9. However, several 
questions remain unanswered with regards to how bariatric surgery can play a role in returning 
the body’s immune system and metabolic profile to a state of normalcy. 
5.1 Bariatric Surgery and Response to the Influenza Vaccine. 
 A key question being examined was whether or not bariatric surgery could improve an 
individual’s response to the influenza vaccine. Our results showed that the median HAI titer of 
participants decreased from a titer of 80.00 before surgery to a titer of 60.00 after surgery. The 
post-surgery titer became more similar to the median HAI titer observed in lean control patients 
(40.00). However, our results indicated that there was no statistical difference between HAI titers 
before surgery and HAI titers after surgery (p = 0.50). Furthermore, our findings showed that 
neither pre-surgery nor post-surgery HAI titers were statistically different from the HAI titers of 
lean control participants (p= 0.72 and 0.99 respectively). When HAI titers were stratified based 
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on sex and race, HAI titers were still not statistically different pre vs. post-bariatric surgery or 
from lean control participants.  
 Our results would suggest that bariatric surgery has no significant impact on the body’s 
production of serum antibodies against the influenza virus after vaccination. Furthermore, our 
results suggest that an obese individuals antibody production in response to vaccination is not 
significantly different from that of a healthy individual’s. However, it is well established that 
obesity does lead to increased mortality and susceptibility to influenza virus. Therefore, we 
suggest that serum antibody levels induced by vaccination may not be not be an accurate 
measure of the body’s ability to protect itself from the influenza virus, and other factors should 
be investigated instead (see future directions). 
5.2 Changes in Metabolic Parameters as a Result of Surgery 
 Another key question this study aimed to answer was whether or not bariatric surgery 
could help re-establish a state of metabolic normalcy. A total of 11 metabolic variables were 
statistically different pre vs. post-surgery. Of the nutrients and metabolic hormones/peptides that 
were statistically different before and after surgery, data regarding four (vitamin D, vitamin B-
12, glucagon, and visfatin) were normally distributed.  
On average, vitamin D and B-12 levels both increased after surgery. There was no data 
regarding the lean participants vitamin D and B-12 levels, so comparisons to a healthy standard 
were made based on the Institute of Medicines (IOM) recommendations. The IOM recommends 
that adults need serum levels of at least 20 ng/mL for vitamin D and at least 250pg/mL for 
vitamin B-12 17,18. Both pre and post-surgery vitamin D and B-12 levels fell within a healthy 
range. Glucagon and visfatin levels both decreased after surgery and became more similar to 
levels seen in the control group. Glucagon levels were statistically different from the control 
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group both pre and post-surgery. Visfatin levels were significantly different from the control 
group pre-surgery but not post-surgery indicating that there was a return to normalcy.   
Both vitamin D and B-12 levels are typically lower in obese individuals than healthy 
weight individuals19,28. Glucagon and visfatin levels are both typically elevated in obese 
individuals compared to healthy weight individuals22,26. The trends in these nutrient and hormone 
levels imply that bariatric surgery shifted their levels closer to normalcy, and in the case of 
visfatin re-established normalcy. 
For the remaining seven variables, three saw a return to normalcy. The median A1c, 
insulin, and resistin levels decreased after surgery and became more similar to the healthy 
control median level. Furthermore, our results showed that there was a significant difference 
between pre-surgery levels and healthy control levels but no significant difference between the 
post-surgery levels and healthy control levels for these variables.  
Obesity typically leads to the onset of type II diabetes, a disease characterized by insulin 
resistance. Therefore, obese individuals typically experience hyperinsulinemia and increased 
A1c levels30. Resistin levels are also typically elevated in obese individuals2. Therefore, our 
findings indicate that bariatric surgery helped return the levels of these metabolic variables to a 
state of normalcy. Our results showed that bariatric surgery did not have an impact on the 
number of type II diabetes diagnoses or on glucose levels, which is not in accordance with what 
our data states about insulin and A1c levels. However, it should be noted that all patients that 
were diagnosed with diabetes before surgery had their diagnoses removed 6 months after 
surgery.  
Of the last four variables which did not see a return to normalcy, the median levels of 
three variables decreased after surgery. The median C-peptide and leptin levels decreased after 
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surgery and became more similar to the median level seen in healthy controls. However, both of 
these variables remained statistically different from the lean controls after surgery. The median 
Ghrelin level also decreased after surgery and was statistically different from the control group, 
however, it became more dissimilar from the lean control group than before surgery. Lastly, the 
median adiponectin level increased after surgery and became more similar to the median 
adiponectin level of the control group. Adiponectin levels were not statistically different form the 
levels seen in the control group pre or post-surgery. 
Leptin levels are typically increased in obese individuals and adiponectin levels are 
decreased26. Our findings support that bariatric surgery helps shift leptin and adiponectin levels 
to levels seen in healthy individuals. However, post-surgery levels for Leptin were statistically 
different compared to lean control levels, implying that surgery is not an effective means of 
restoring leptin to normalcy or that more time after surgery needs to pass before significant 
change is seen. Adiponectin levels, although seeing a significant change after surgery, were not 
statistically different from the control group before or after surgery, implying that adiponectin 
was not significantly altered by obesity in our study population. Ghrelin levels were lower in the 
pre-surgery group compared to the control group, which was expected since ghrelin is typically 
downregulated in obesity23. However, after surgery levels continued to drop rather than increase. 
This may be a direct consequence of the surgery itself which removes the gastric fundus (the 
portion of the stomach that produces ghrelin) and would therefore result in lower amounts of 
ghrelin produced31.  
In summary, obesity led to trends in circulating nutrients and metabolic 
hormones/peptides that indicate a shift toward normality. It can only be said that 4 of these 
variables did indeed return to a state of normalcy based on statistical analysis. Of the 4 variables, 
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3 were markers of type II diabetes (visfatin, insulin, A1c). The return to normalcy of these 
variables in addition to the decrease in the number of type II diabetes diagnoses implies a 
remedial effect of bariatric surgery on this particular co-morbidity. Furthermore, the overall trend 
seen in the metabolic variables implies a remedial effect of bariatric surgery on the host 
metabolic profile.  
5.3 Serum Antibody levels as they relate to the Metabolic Profile 
 The purpose in evaluating the relationships between vaccine induced serum antibody 
levels and metabolic parameters was to determine if the compromised response to the influenza 
vaccine seen in obese individuals could be linked to their altered metabolic profile. However, our 
findings indicated that no significant correlations were found between HAI titers and the 
nutrients or metabolic hormones/peptides measured. Correlations between variables were tested 
for individually in the three sub-groups (pre-surgery, post-surgery, and lean controls) and with 
the three sub-groups combined.  
5.4 Limitations 
 One limitation of this study was the sample size. Our study included a total of 12 surgery 
patients, after accounting for outliers, and 15 participants in the control group for a total of 27 
participants. The small sample size is likely the reason that the data for many variables was not 
normally distributed. Data that is not normally distributed is not generalizable to population. 
Therefore, while we can draw many conclusions for our study population based on our results, 
we cannot definitively not apply our conclusions to the wider population. Only data in regards to 
visfatin, insulin, A1c, and resistin were normally distributed, and therefore, our data in regards to 
these variables are applicable to the general population. 
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 Another limitation of the study was that UNC Healthcare’s EPIC database did not contain 
data regarding every participant in the study for certain variables. This made it impossible to 
draw a comparison of bariatric surgery participants vitamin D and B-12 levels to those of the 
lean controls. Additionally, some of the results of the bio-plex immunoassay were inconclusive, 
so data for some participants metabolic hormones and peptides levels was missing. These two 
limitations further decreased the sample size for data regarding certain variables and exacerbated 
the effects of an already small sample size, as mentioned in in the first limitation. 
5.5 Future Directions  
 We recommend that this same study be carried out with a larger sample size to verify our 
findings. Due to our limitations, certain aspects of our study are not generalizable to the wider 
population and certain analyses may be skewed. We also recommend carrying out this for a 
longer duration of time in order to evaluate the effects of bariatric surgery beyond 4 months. This 
could provide further insights in regard to the procedure as it relates to influenza vaccination and 
host metabolism in case some of its effects require more time to surface. Furthermore, we 
recommend T-cell function be analyzed before and after bariatric surgery in order to determine if 
bariatric surgery has a significant impact on this aspect of immunity. T-cells from influenza 
vaccinated obese adults have been shown to be less activated when stimulated with vaccine 
strains of influenza16. Therefore, impaired T-cell function in obese individuals could be a reason 
for increased susceptibility to influenza. A more complete understanding of bariatric surgery’s 
impact on T-cell function could help discern whether or not this surgery can help improve the 
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